SLFN11 and small cell lung carcinoma: Next we examined the talazoparib-temozolomide combination in xenograft models using three SCLC cell lines harboring different SLFN11 and MGMT status: NCI-H209 (high SLFN11, high MGMT), NCI-H841 (low SLFN11, high MGMT) and NCI-H1092 (high SLFN11, low MGMT) (Table S3) (Figure 5D).